Skip to main content
. 2016 Nov 14;26(4):e1544. doi: 10.1002/mpr.1544

Table 1.

Test–retest reliability (Kappa) of six child psychiatric disorders classified using five standardized diagnostic interviews administered to mothers and youth sampled from clinic‐referred and community populations

ADHD
Instrument Reference Sample1 M/F or total N 2 Age in years3 Res4 Interval (days)5 ADHD ODD CD SAD GAD MDD Ave7
CAPA Eggera clin 307 2–5 P 3–28 .74 .57 .60 .60 .39 .72 .60
Angoldb clin 77 10–16 P 1–11 n/a n/a .55 n/a .79 .90 .75
K‐SADS‐PL Chambersc clin 31/21 6–17 Co <3 n/a n/a .63 n/a .24 .54 .47
DISC Hod clin 78 9–18 P 22 .81 .55 n/a n/a .51 .82 .67
Hod clin 78 9–18 Y 22 .25 .41 n/a n/a .37 .58 .40
Bravoe clin 97/49 4–17 P 12 .506 .456 .476 .646 .446 .486 .49
Bravoe clin 83 11–17 Y 12 n/a n/a .62 .18 n/a .15 .32
Shafferf clin 84 9–17 P 6.6 .79 .54 .43 .58 .65 .66 .61
Shafferf clin 82 9–17 Y 6.6 .42 .51 .65 .46 n/a .92 .59
Schwab‐Stoneg clin 39 11–17 P 7–21 .55 .88 .87 n/a n/a .72 .76
Schwab‐Stoneg clin 41 11–17 Y 7–21 n/a .16 .55 .72 n/a .77 .55
Flisherh comb 71/34 15.0 (2.2) P 14 .56 .66 n/a n/a .457 .66 .58
Jenseni clin 73/24 9–17 P 13 .69 .67 .70 n/a .58 .69 .67
Jenseni clin 73/24 9–17 Y 13 .59 .46 .86 n/a .39 .38 .54
Jenseni comm 129/149 9–17 P 21 .57 .65 .66 n/a .40 .00 .46
Jenseni comm 129/149 9–17 Y 21 .43 .23 .60 n/a .30 .29 .37
Bretonj comm 260 6–14 P 14 .60 .56 n/a .44 .57 .32 .50
Bretonj comm 145 12–14 Y 14 n/a n/a .49 .59 .53 .55 .54
Riberak comm 124 9–17 Co <14 .53 .56 .82 .46 –.03 .29 .44
Schwab‐Stonel comm 130/117 9–18 P 1–15 .606 .686 .566 .456 .606 .556 .57
Schwab‐Stonel comm 130/117 9–18 Y 1–15 .106 .186 .646 .276 .286 .376 .31
DICA Boylem comm 210 6–16 P 7–21 .59 .51 .21 .32 .57 .70 .48
Boylen comm 137 12–16 Y 7–21 .24 .28 .92 n/a .54 .45 .49
Ezpeletao clinic 110 7–177 P 11 .53 n/a .77 .56 .59 .10 .51
Ezpeletao clinic 110 7–177 Y 11 .79 n/a .27 .39 .47 .66 .52
Ezpeletap comm 244 3–7 P 4–40 .83 .65 n/a .76 .50 .67 .68
MINI‐KID Sheehanq comb 83 6–17 Co 1–5 .87 .71 .85 .70 .64 .75 .75
Ave Parent/Co8 .65 .61 .62 .52 .46 .56 .57
Ave Youth9 .34 .32 .67 .44 .40 .50 .45

Note: CAPA, Child and Adolescent Psychiatric Assessment; K‐SADS‐PL, Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime; DISC, Diagnostic Interview Schedule for Children; DICA, Diagnostic Interview for Children and Adolescents; MINI‐KID, Mini International Neuropsychiatric Interview for Children and Adolescents; ADHD, attention deficit hyperactivity disorder; ODD, oppositional defiant disorder; CD, conduct disorder; SAD, separation anxiety disorder; GAD, generalized anxiety disorder; MDD, major depressive disorder; n/a, not assessed.

1

Sample: clin = clinic, comb = clinic and community, comm = community.

2

M/F = males/females or total N = total sample size.

3

Age in years = minimum/maximum or mean, standard deviation.

4

Res = Respondent, P = parent; Y = youth; Co = combined parent and youth.

5

Interval (days) = minimum‐maximum or mean.

6

Age groups 7–11 and 12–17 years combined and average kappa reported.

7

Ave = mean kappa value across disorders for parent/combined and for youth.

8

Ave Parent/Co = mean kappa value for disorders assessed by parents averaged across studies.

9

Ave Youth = mean kappa value for disorders assessed by youth averaged across studies.

a

Egger et al. (2006);

b

Angold and Costello (1995);

c

Chambers et al. (1985);

d

Ho et al. (2005);

e

Bravo et al. (2001);

f

Shaffer et al. (2000);

g

Schwab‐Stone et al. (1993);

h

Flisher, Sorsdahl, and Lund (2012)

i

Jensen et al. (1995)

j

Breton, Bergeron, Valla, Berthiaume, and St‐Georges (1998);

k

Ribera et al. (1996);

l

Schwab‐Stone et al. (1996);

m

Boyle et al. (1997);

n

Boyle et al. (1993b);

o

Ezpeleta, de la Osa, Domènech, Navarro, and Losilla (1997);

p

Ezpeleta, de la Osa, Granero, Domènech, and Reich (2011);

q

Sheehan et al. (2010).